Please assess the completion status of the following clinical trial:

Trial Title: Somatuline Predictive Factors in Acromegaly and NET

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Written informed consent (also mandatory in case of retrospective documentation of subject data)~* Diagnosis of acromegaly or NET with the intention to be treated with ATG or already on treatment with ATG~Exclusion Criteria:~* The subject has already been included in this study~* Participation in an interventional trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Neuroendocrine Tumours (Type: None): The subject will receive treatment as prescribed by the investigator and in accordance with the current recommendations, routine practice and local regulations.
- Acromegaly (Type: None): The subject will receive treatment as prescribed by the investigator and in accordance with the current recommendations, routine practice and local regulations.

Based on this trial design, predict the completion outcome and termination type (if applicable).